← Leaderboards
Constance Ann Benson
University Of California, San Diego
$316,153,156
Attributed
$319,080,191
Total exposure
15
Grants
8
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $40.3M · FY2005–24$50M$37.5M$25M$12.5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$319,080,191 · 15
By mechanism
U01$269,337,132 · 4
UM1$42,042,757 · 1
R01$5,854,071 · 1
M01$1,846,231 · 9
Top collaborators
- Sara H. Browne7 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Christopher K Glass$71,096,171
- Joseph G Gleeson$42,611,227
- Mark H Tuszynski$42,403,260
- Mark Howard Ginsberg$41,669,148
- Michael Karin$60,628,305
Others in their field
Top investigators on “Hiv Infections”
- Wafaa M. El-Sadr · Columbia University Health Sciences$965,259,079
- Lawrence Corey · Fred Hutchinson Cancer Center$728,701,834
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$467,263,656
- Judith S. Currier · University Of California Los Angeles$466,447,923
- Richard Marlink · Elizabeth Glaser Pediatric Aids Fdn$457,210,249
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$398,445,678
Research focus
Hiv InfectionsClinical TrialsClinical ResearchResearch PersonnelAnti-Retroviral AgentsPreventionEvaluationParticipantInfectionCollaborationsPreventClinical Research SiteAreaResearch PriorityLeadershipPathogenesisTherapeutic Clinical TrialResourcesPerformanceCaliforniaPersonsBaseUniversitiesViral
Grant awards (64)
UCSD Collaborative Clinical Trials Unit$3,587,015
UM1 · FY2024 · AI · contact PI
UCSD Collaborative Clinical Trials Unit$3,234,709
UM1 · FY2023 · AI · contact PI
UCSD Collaborative Clinical Trials Unit$3,623,403
UM1 · FY2022 · AI · contact PI
UCSD Collaborative Clinical Trials Unit$3,634,455
UM1 · FY2021 · AI · contact PI
The UCSD CD4 Collaborative Clinical Trial Unit$3,763,076
UM1 · FY2020 · AI · contact PI
Pooled and conventional nucleic acid testing strategies for SARS-CoV-2 to screen direct care research staff and protect HIV patients$845,588
UM1 · FY2020 · AI · contact PI
The UCSD CD4 Collaborative Clinical Trial Unit$4,550,799
UM1 · FY2019 · AI · contact PI
A Novel Wireless Ingestible Sensor System for Measurement of Medication Adherence in HIV Treatment and Prevention$688,267
R01 · FY2019 · MH
The UCSD CD4 Collaborative Clinical Trial Unit$2,184,106
UM1 · FY2018 · AI · contact PI
A Novel Wireless Ingestible Sensor System for Measurement of Medication Adherence in HIV Treatment and Prevention$1,467,734
R01 · FY2018 · MH
A Novel Wireless Ingestible Sensor System for Measurement of Medication Adherence in HIV Treatment and Prevention$200,000
R01 · FY2018 · MH
The UCSD CD4 Collaborative Clinical Trial Unit$2,370,023
UM1 · FY2017 · AI · contact PI
A Novel Wireless Ingestible Sensor System for Measurement of Medication Adherence in HIV Treatment and Prevention$955,505
R01 · FY2017 · MH
A Novel Wireless Ingestible Sensor System for Measurement of medication Adherence in HIV Treatment and Prevention$562,506
R01 · FY2017 · MH
The UCSD CD4 Collaborative Clinical Trial Unit$2,407,704
UM1 · FY2016 · AI · contact PI
A Novel Wireless Ingestible Sensor System for Measurement of Medication Adherence in HIV Treatment and Prevention$980,060
R01 · FY2016 · MH
A Novel Wireless Ingestible Sensor System for Measurement of Medication Adherence in HIV Treatment and Prevention$999,999
R01 · FY2015 · MH
The UCSD CD4 Collaborative Clinical Trial Unit$103,303
UM1 · FY2015 · AI · contact PI
The UCSD CD4 Collaborative Clinical Trial Unit$5,626,528
UM1 · FY2014 · AI · contact PI
UCSD Department of Medicine HIV/AIDS Clinical Trials Unit$3,192,904
UM1 · FY2013 · AI · contact PI
UCSD Department of Medicine HIV/AIDS Clinical Trials Unit$2,919,144
UM1 · FY2012 · AI · contact PI
UCSD Department of Medicine HIV/AIDS Clinical Trials Unit$4,646,184
U01 · FY2011 · AI · contact PI
UCSD Department of Medicine HIV/AIDS Clinical Trials Unit$4,754,262
U01 · FY2010 · AI · contact PI
CLINICAL TRIAL: ADULT AIDS CLINICAL TRIALS GROUP LONGITUDINAL LINKED RANDOMIZED$405
M01 · FY2010 · RR · contact PI
AIDS Clinical Trials Group Network$28,739,656
U01 · FY2009 · AI · contact PI
UCSD Department of Medicine HIV/AIDS Clinical Trials Unit$4,758,033
U01 · FY2009 · AI · contact PI
AIDS Clinical Trials Group Network$1,130,883
U01 · FY2009 · AI · contact PI
AIDS Clinical Trials Group Network$36,890,085
U01 · FY2008 · AI · contact PI
UCSD Department of Medicine HIV/AIDS Clinical Trials Unit$3,121,542
U01 · FY2008 · AI · contact PI
ADULT ACTG CENTRAL GROUP$258,060
U01 · FY2008 · AI · contact PI
CLINICAL TRIAL: TRIAL IN ANTIRETROVIRAL NAIVE HIV SUBJECTS$2,467
M01 · FY2008 · RR · contact PI
AIDS Clinical Trials Group Network$28,900,058
U01 · FY2007 · AI · contact PI
UCSD Department of Medicine HIV/AIDS Clinical Trials Unit$2,036,987
U01 · FY2007 · AI · contact PI
ADULT ACTG CENTRAL GROUP$541,530
U01 · FY2007 · AI · contact PI
TRIAL IN ANTIRETROVIRAL NAIVE HIV SUBJECTS$188,986
M01 · FY2007 · RR · contact PI
AIDS Clinical Trials Group Network$26,268,846
U01 · FY2006 · AI · contact PI
ADULT ACTG CENTRAL GROUP$10,734,226
U01 · FY2006 · AI · contact PI
SAN DIEGO AIDS CLINICAL TRIAL UNIT$1,750,565
U01 · FY2006 · AI · contact PI
ADULT ACTG CENTRAL GROUP$20,164,621
U01 · FY2005 · AI
ADULT ACTG CENTRAL GROUP$6,604,133
U01 · FY2005 · AI
SAN DIEGO AIDS CLINICAL TRIAL UNIT$2,074,602
U01 · FY2005 · AI
ADULT ACTG CENTRAL GROUP$1,673,290
U01 · FY2005 · AI
ACTG A5001 - LONGITUDINAL LINKED RANDOMIZED TRIALS (ALLRT) PROTOCOL$177,864
M01 · FY2005 · RR
ACTG A5030-VALGANCICLOVIR PRE-EMPTIVE THERAPY FOR CYTOMEGALOVIRUS (CMV) VIREMIA$118,883
M01 · FY2005 · RR
IPCP 01 STUDY OF THE EPIMMUNE HIV-1 CTL EPITOPE-BASED DNA VACCINE$39,627
M01 · FY2005 · RR
ACTG 362-METAB,CARDIOVAS&NEUROLCOMPLICA'S IN SUBJ'S W/PAST CD4 CELL$36,862
M01 · FY2005 · RR
ADULT ACTG CENTRAL GROUP$37,436,898
U01 · FY2004 · AI
SAN DIEGO AIDS CLINICAL TRIAL UNIT$2,123,616
U01 · FY2004 · AI
IPCP 01 Study of the Epimmune HIV-1 DNA Vaccine$227,531
M01 · FY2004 · RR
ACTG A5001 - LONGITUDINAL LINKED RANDOMIZED TRIALS$144,976
M01 · FY2004 · RR
ACTG A5030-Valganciclovir Pre-Emptive Therapy for CMV$93,294
M01 · FY2004 · RR
ACTG 362-METABOLIC, CARDIO &NEURO COMPLICATIONS$20,136
M01 · FY2004 · RR
ADULT ACTG CENTRAL GROUP$20,068,620
U01 · FY2003 · AI
ADULT ACTG CENTRAL GROUP$24,660,435
U01 · FY2002 · AI
FTC VS. LAMIVUDINE IN TRIPLE ANTIRETROVIRAL THERAPY$190,747
M01 · FY2002 · RR
HIV &CMV VIRAL BURDEN &DEV OF CMV END ORGAN DISEASE: HIV INFECTION$190,747
M01 · FY2002 · RR
HIV &CMV VIRAL BURDEN &DEV OF CMV END ORGAN DISEASE: HIV INFECTION$190,747
M01 · FY2001 · RR
FTC VS. LAMIVUDINE IN TRIPLE ANTIRETROVIRAL THERAPY$190,747
M01 · FY2001 · RR
HIV &CMV VIRAL BURDEN &DEV OF CMV END ORGAN DISEASE: HIV INFECTION$0
M01 · FY2001 · RR
FTC VS. LAMIVUDINE IN TRIPLE ANTIRETROVIRAL THERAPY$0
M01 · FY2001 · RR
HIV &CMV VIRAL BURDEN &DEV OF CMV END ORGAN DISEASE: HIV INFECTION$32,212
M01 · FY2000 · RR
FTC VS. LAMIVUDINE IN TRIPLE ANTIRETROVIRAL THERAPY$0
M01 · FY2000 · RR
FTC VS. LAMIVUDINE IN TRIPLE ANTIRETROVIRAL THERAPY$0
M01 · FY2000 · RR
HIV &CMV VIRAL BURDEN &DEV OF CMV END ORGAN DISEASE: HIV INFECTION$0
M01 · FY2000 · RR